Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 255.50	1.8%	4.5%	CHF 205.2b	CHF 303.36	PE19.2x	E11.5%	3.8%
NOVN Novartis	CHF 88.70	1.2%	4.5%	CHF 177.3b	CHF 103.92	PE16.6x	E7.0%	3.7%
LONN Lonza Group	CHF 535.80	0.6%	51.5%	CHF 38.7b	CHF 636.90	PE67.5x	E23.4%	0.7%
GALD Galderma Group	CHF 100.64	2.3%	n/a	CHF 23.9b	CHF 99.88	PS6.1x	E44.6%	n/a
SDZ Sandoz Group	CHF 37.17	0.3%	37.4%	CHF 16.3b	CHF 43.50	PS1.8x	E34.9%	1.2%
BANB Bachem Holding	CHF 57.90	0.2%	-10.9%	CHF 4.3b	CHF 83.57	PE38.2x	E17.9%	1.4%
SFZN Siegfried Holding	CHF 986.00	0.7%	14.7%	CHF 4.2b	CHF 1,187.67	PE32.8x	E13.7%	0.4%
DESN Dottikon ES Holding	CHF 221.00	2.1%	-3.5%	CHF 3.1b	CHF 350.00	PE40.4x	S16.4%	0%
TECN Tecan Group	CHF 202.60	-0.2%	-41.0%	CHF 2.6b	CHF 284.86	PE25.6x	E14.8%	1.5%
SKAN SKAN Group	CHF 76.20	-0.3%	-5.7%	CHF 1.7b	CHF 90.67	PE53.1x	E18.7%	0.5%
COPN Cosmo Pharmaceuticals	CHF 63.70	4.1%	25.1%	CHF 1.0b	CHF 97.30	PE15.6x	E17.2%	3.0%
PPGN PolyPeptide Group	CHF 28.40	-0.7%	62.1%	CHF 936.7m	CHF 36.25	PS3.1x	E64.2%	0%
KURN Kuros Biosciences	CHF 21.35	5.7%	511.7%	CHF 802.2m	n/a	PS15.3x	n/a	n/a
BSLN Basilea Pharmaceutica	CHF 41.35	0.5%	17.1%	CHF 501.2m	CHF 77.25	PS3.4x	E22.0%	0%
NWRN Newron Pharmaceuticals	CHF 8.95	5.4%	80.8%	CHF 174.2m	CHF 14.39	PS26.5x	E56.5%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 13.82	20.8%	40.9%	CHF 167.3m	CHF 32.00	PE2.7x	E35.4%	n/a
IDIA Idorsia	CHF 0.82	12.6%	-61.1%	CHF 154.8m	CHF 1.00	PS2.1x	E17.4%	n/a
MOLN Molecular Partners	CHF 4.06	-12.3%	18.0%	CHF 149.7m	CHF 9.75	PS24.9x	E-1.9%	n/a
XLS Xlife Sciences	CHF 25.40	-1.6%	-49.1%	CHF 145.8m	n/a	PE6.9x	n/a	n/a
CURN Curatis Holding	CHF 13.00	2.4%	n/a	CHF 63.0m	CHF 20.00	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 4.21	2.7%	111.6%	CHF 52.8m	n/a	PS6.1x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.057	-1.0%	24.3%	CHF 5.6m	n/a	PS9.5x	E0.09%	n/a
KNRS Kinarus Therapeutics Holding	CHF 16.13	5.9%	-66.7%	CHF 3.9m	n/a	n/a	n/a	n/a
SPEX Spexis	CHF 0.065	0%	58.5%	CHF 2.0m	n/a	PS7.4x	n/a	n/a